Pascal Soriot
Pascal Soriot | |
|---|---|
.jpg) Soriot in 2019 | |
| Born | Pascal Claude Roland Soriot 23 May 1959 France |
| Citizenship |
|
| Education | École nationale vétérinaire d'Alfort HEC Paris |
| Occupation | Businessman |
| Years active | 1982–present |
| Title | CEO, AstraZeneca |
| Term | 2012– |
| Children | 2 |
| Honours | Knight Bachelor |
Sir Pascal Claude Roland Soriot (born 23 May 1959) is a French-born Australian businessman and chief executive of the British-Swedish multinational pharmaceutical and biotechnology company AstraZeneca.[1]
Early life
[edit]Soriot was born in France on 23 May 1959.[2] His father died when he was 20.[3]
He studied veterinary medicine at the École nationale vétérinaire d'Alfort at Maisons-Alfort in Paris.[2] He later obtained an MBA at HEC Paris.[1]
Career
[edit]Roussel Uclaf
[edit]In April 1986, he joined Roussel Uclaf (formerly France's second largest pharmaceutical company, until bought by Hoechst AG in 1997) as a salesman in Australia.[2][4] In 1996, he became General Manager of Hoechst Marion Roussel in Australia, moving to Tokyo in April 1997.[5]
Aventis
[edit]In 2000 he moved to Aventis in America, becoming chief operating officer of Aventis USA in 2002, which became Sanofi Aventis USA in 2004.[6][7]
Roche
[edit]He joined Roche in 2006 as head of marketing.[5] From April 2009 to 2010, he was chief executive of the Roche subsidiary Genentech. He rejoined Roche Pharma AG in 2010 as chief operating officer.[8]
AstraZeneca
[edit]In August 2012 he was named as the new chief executive of AstraZeneca,[9] the world's fifth largest pharmaceutical company, when aged 53. He took up the post on 1 October 2012.[10][11]
In July 2017, it was reported that Soriot would become the next CEO of Israel-based Teva Pharmaceutical Industries, succeeding Erez Vigodman, though this was soon denied.[12][13][14]
In September 2018, he made headlines commenting on his pay of £9.4m in salary and bonuses. 'The truth is I’m the lowest-paid CEO in the whole industry', he said. 'It is annoying to some extent. But at the end of the day it is what it is.'[15]
In 2023, Soriot was the highest paid CEO of the major European pharmaceutical companies, as he earned $21.3 million. That was a nearly 12 per cent increase over 2022.[16]
In March 2024, Soriot was awarded the President's Medal by the Society of Chemical Industry for leading AstraZeneca’s COVID-19 vaccination programme.[17]
Personal life
[edit]He is married and has two children.[18] He has three brothers, all of whom are doctors.[3]
Soriot was knighted in the 2022 Birthday Honours for services to UK life sciences and the response to COVID-19.[19] He qualifies for a substantive knighthood rather than an honorary one by virtue of being an Australian citizen.[20]
He counts cycling, horse riding and skiing as hobbies.[5]
References
[edit]- ^ a b "Executive Profile: Pascal Soriot". Bloomberg. Retrieved 3 April 2015.
- ^ a b c "Pascal Soriot: Leader of the great escape". Financial Times. June 2014. Archived from the original on 4 March 2023. Retrieved 26 January 2017.
- ^ a b Ralph, Alex (17 May 2019). "A drugs giant that loves to blind rivals with science". The Times. ISSN 0140-0460. Retrieved 17 May 2019.
- ^ "Pascal Soriot". Roche.com. Archived from the original on 29 December 2012. Retrieved 26 January 2017.
- ^ a b c Ward, Andrew (21 January 2016). "Pascal Soriot on his rise to become CEO of AstraZeneca". Financial Times. Retrieved 8 March 2024.
- ^ "Roche | Pascal Soriot". www.roche.com. Retrieved 8 March 2024.
- ^ "SANOFI-AVENTIS". www.sec.gov. Retrieved 8 March 2024.
- ^ "AstraZeneca Names Roche's Pascal Soriot as CEO". Bloomberg. 28 August 2012. Retrieved 6 February 2013.
- ^ Rowley, Emma (28 August 2012). "AstraZeneca appoints Roche's Pascal Soriot as new chief". The Telegraph. Retrieved 26 January 2017.
- ^ Kollewe, Julia (28 August 2012). "AstraZeneca appoints new chief executive". The Guardian. ISSN 0261-3077. Retrieved 8 March 2024.
- ^ "AstraZeneca Names Its Next Chief". The New York Times. 28 August 2012. ISSN 0362-4331. Retrieved 8 March 2024.
- ^ Boland, Hannah (14 July 2017). "Pascal Soriot looks set to stay as AstraZeneca chief". The Telegraph – via www.telegraph.co.uk.
- ^ "AstraZeneca's CEO Soriot to join Israeli drugs company Teva: report". Reuters. 14 May 2014. Retrieved 12 July 2017.
- ^ "Israeli newspaper reports that AstraZeneca CEO Pascal Soriot has agreed to take the helm at Teva – ENDPOINTS NEWS". Endpts.com. Retrieved 12 July 2017.
- ^ Meddings, Sabah (6 October 2023). "Salary size matters, says Astra Zeneca boss on £9.4m" – via www.thetimes.co.uk.
- ^ Staff, A. O. L. (5 March 2024). "Worse than COVID shutdown. Pasco businesses in dire straits over overpass closure project". www.aol.com. Retrieved 7 March 2024.
- ^ "AstraZeneca CEO Sir Pascal Soriot Awarded Top Science Honour". PharmiWeb.com. Retrieved 11 September 2024.
- ^ James Ashton (16 May 2014). "Astrazeneca chief Pascal Soriot: I can carry on curing the company, says scientist in £63bn bid battle". Standard.co.uk. Retrieved 26 January 2017.
- ^ "No. 63714". The London Gazette (Supplement). 1 June 2022. p. B2.
- ^ "AstraZeneca's Pascal Soriot awarded British knighthood for services to UK life sciences and leadership in the global response to the COVID pandemic". AstraZeneca.com. June 2022. Retrieved 14 June 2022.
External links
[edit]- Roche Archived 3 March 2016 at the Wayback Machine
| International | |
|---|---|
| National | |
